NFCR Writer David Perry, Author at NFCR

NFCR Writer David Perry

Hormone Therapy: Influencing Breast Cancer Treatment and Beyond

While recent medical discoveries, from drugs to imaging techniques, continue to revolutionize cancer care, none of them would be possible without foundations having been laid years, or even decades, earlier. Groundbreaking work by the late endocrinologist Jack Gorski, Ph.D., who passed away in 2006 and was funded by the National…...

Read more

The Muscle Cancer That Isn’t

In a proof-positive that cancer research still has miles to cover, a pediatric cancer long associated with aberrant muscle cells has now been found to arise from cells that would normally develop into cells lining blood vessels. Oncologists at St. Jude Children’s Research Hospital researching rhabdomyosarcoma, the most prevalent soft…...

Read more

Early Cancer Screening 101

True fact: It was nearly a century ago, in 1924, when a Johns Hopkins doctor by the apt name of John Bloodgood predicted in a New York Times editorial that early detection of cancer would wipe the disease form humanity in one fell swoop. As of yet, that particular future…...

Read more

Dr. Bea Mintz: The Pioneer of Transgenics—and So Much More

  Changing a cancerous cell into a normal cell would seem to be the very definition of a holy grail: a lofty goal that is all but impossible to achieve. And yet, it has already been done. It was 1975 when the seminal work of Dr. Beatrice (“Bea”) Mintz showed…...

Read more

Crizotinib Plus Radiation May Reduce NF2-Related Hearing Loss

A study co-authored by National Foundation for Cancer Research Fellow Dr. Rakesh Jain hints that adding the cancer drug crizotinib to the radiation therapy for tumors associated with neurofibromatosis 2 (NF2) may lessen the hearing loss that often precipitates from radiotherapy. Although not a cancer, NF2 is characterized by benign…...

Read more

Targeted Lung Cancer Therapy

A Match Made Possible A discovery by a team led by Massachusetts General Hospital’s Daniel Haber, M.D., Ph.D., a physician-scientist supported by the National Foundation for Cancer Research since 2003, now represents a source of hope for many patients with metastatic lung cancer. He and his colleagues correctly linked very…...

Read more

New Type of Lung Cancer Identified

A research team at Cold Spring Harbor Laboratory discovered a new kind of small-cell lung cancer (SCLC). While the general public may not consider this particularly good news, the identification paves the way for developing more specific and personalized medicine approaches to target this previously unnoticed form of the disease....

Read more

November Is Pancreatic Cancer Awareness Month

Even in the company of other vicious diseases, pancreatic cancer is particularly nasty: The one-year relative survival rate is 20% and the five-year rate is 7%. It ranks third in cancer-related deaths in the United States, and it is expected that over 55,000 Americans will be diagnosed this year alone.…...

Read more

Liquid Biopsy Advances: Capturing Metastatic Cancer Cells

A novel instrument for detecting cancer cells in the blood could lead to individualized cancer treatments for patients suffering metastasis. Developed by a Massachusetts General Hospital team led by Daniel Haber, M.D., Ph.D., a renowned cancer scientists supported by the National Foundation for Cancer Research since 2003, the business card-sized…...

Read more

Viagra: A Colon Cancer Risk Mitigator?

Researchers at the Georgia Cancer Center and Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University found that a small, daily dose of Viagra significantly reduces colorectal cancer risk....

Read more